A detailed history of Petrus Trust Company, Lta transactions in Enovis Corp stock. As of the latest transaction made, Petrus Trust Company, Lta holds 13,456 shares of ENOV stock, worth $591,391. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,456
Previous 16,796 19.89%
Holding current value
$591,391
Previous $759,000 23.72%
% of portfolio
0.06%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.57 - $48.1 $135,503 - $160,654
-3,340 Reduced 19.89%
13,456 $579,000
Q2 2024

Aug 14, 2024

BUY
$44.56 - $62.43 $333,086 - $466,664
7,475 Added 80.2%
16,796 $759,000
Q1 2024

May 15, 2024

SELL
$55.44 - $63.8 $148,523 - $170,920
-2,679 Reduced 22.33%
9,321 $582,000
Q4 2023

Feb 14, 2024

BUY
$43.67 - $57.07 $236,560 - $309,148
5,417 Added 82.29%
12,000 $672,000
Q3 2023

Nov 14, 2023

BUY
$51.65 - $65.54 $340,011 - $431,449
6,583 New
6,583 $347,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.38B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.